These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1537362)

  • 1. Ascorbic acid and alkaptonuria.
    Kamoun P; Coude M; Forest M; Montagutelli X; Guenet JL
    Eur J Pediatr; 1992 Feb; 151(2):149. PubMed ID: 1537362
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion.
    Forslind K; Wollheim FA; Akesson B; Rydholm U
    Clin Exp Rheumatol; 1988; 6(3):289-92. PubMed ID: 3180550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alkaptonuria (homogentisic aciduria)].
    Takita H
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):328-31. PubMed ID: 9590059
    [No Abstract]   [Full Text] [Related]  

  • 4. Homogentisic acid oxidase activity in homozygous and heterozygous alkaptonuric mice.
    Coudé M; Montagutelli X; Guenet JL; Kamoun P
    Ann Biol Clin (Paris); 1994; 52(7-8):569-70. PubMed ID: 7840434
    [No Abstract]   [Full Text] [Related]  

  • 5. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
    Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
    Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of the homogentisic acid oxidase from mammalian liver.
    Hudecová S; Straková Z; Krizanova O
    Int J Biochem Cell Biol; 1995 Dec; 27(12):1357-63. PubMed ID: 8581831
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16.
    Montagutelli X; Lalouette A; Coudé M; Kamoun P; Forest M; Guénet JL
    Genomics; 1994 Jan; 19(1):9-11. PubMed ID: 8188247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkaptonuria presenting with ochronotic spondyloarthropathy.
    Al-Mahfoudh R; Clark S; Buxton N
    Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis.
    Braconi D; Laschi M; Amato L; Bernardini G; Millucci L; Marcolongo R; Cavallo G; Spreafico A; Santucci A
    Rheumatology (Oxford); 2010 Oct; 49(10):1975-83. PubMed ID: 20601653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
    Hughes JH; Liu K; Plagge A; Wilson PJM; Sutherland H; Norman BP; Hughes AT; Keenan CM; Milan AM; Sakai T; Ranganath LR; Gallagher JA; Bou-Gharios G
    Hum Mol Genet; 2019 Dec; 28(23):3928-3939. PubMed ID: 31600782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic image (45). Ochronosis].
    ter Borg EJ
    Ned Tijdschr Geneeskd; 2001 Jul; 145(27):1295. PubMed ID: 11475020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ochronosis: a case report with multisystemic affectation, including pericardium].
    Cobos Soler FJ; Molero Cabrilla R
    An Med Interna; 2002 Nov; 19(11):583-5. PubMed ID: 12522896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaptonuria in a 5-year-old boy in Iraq.
    Al-Mefraji SH
    East Mediterr Health J; 2008; 14(3):745-6. PubMed ID: 18720640
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy.
    Wolff JA; Barshop B; Nyhan WL; Leslie J; Seegmiller JE; Gruber H; Garst M; Winter S; Michals K; Matalon R
    Pediatr Res; 1989 Aug; 26(2):140-4. PubMed ID: 2771520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.
    Suzuki Y; Oda K; Yoshikawa Y; Maeda Y; Suzuki T
    J Hum Genet; 1999; 44(2):79-84. PubMed ID: 10083729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric determination of homogentisate using Aspergillus nidulans homogentisate dioxygenase.
    Fernández-Cañón JM; Peñalva MA
    Anal Biochem; 1997 Feb; 245(2):218-21. PubMed ID: 9056215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaptonuria: such a long journey.
    Scriver CR
    Nat Genet; 1996 Sep; 14(1):5-6. PubMed ID: 8782808
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring of a one-month ascorbic acid therapy in an alcaptonuric child; determinations by HPLC.
    Simoni RE; Gomes LN; Faria MS; Barbara Neto J; de Oliveira ML
    J Inherit Metab Dis; 1994; 17(5):632-3. PubMed ID: 7837775
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequence analysis of the homogentisate 1,2 dioxygenase gene in a family affected by alkaptonuria.
    Walter K; Gaa A; Schaefer HE
    J Med Genet; 1999 Aug; 36(8):645-6. PubMed ID: 10465119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.